PD Neurotechnology Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7M
- Investors
-
11
PD Neurotechnology General Information
Description
Developer of a medical device and digital health system designed to remotely and objectively monitor symptoms of patients suffering from Parkinson's disease. The company offers a device that is wearable and non-invasive and helps in continuous monitoring, tracing, recording, and processing of a variety of symptoms, frequently presented in the disease, through the continuous use of the wearable device and a mobile app to facilitate patient-doctor interaction, enabling patients and healthcare providers to improve clinical decision-making and promote patient-physician interaction.
Contact Information
Website
www.pdneurotechnology.comCorporate Office
- 1st Floor Yarnwicke
- 119-121 Cannon Street
- London EC4N 5AT
- England, United Kingdom
Corporate Office
- 1st Floor Yarnwicke
- 119-121 Cannon Street
- London EC4N 5AT
- England, United Kingdom
PD Neurotechnology Timeline
PD Neurotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 01-Jan-2024 | $7M | Completed | Generating Revenue | ||
| 13. Later Stage VC | 08-Dec-2023 | Cancelled | Generating Revenue | |||
| 12. Later Stage VC (Series A) | 25-Apr-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series A) | 25-Aug-2022 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 11-Jan-2021 | Completed | Generating Revenue | |||
| 9. Seed Round | 17-Mar-2020 | Completed | Generating Revenue | |||
| 8. Seed Round | 31-Mar-2020 | Completed | Generating Revenue | |||
| 7. Angel (individual) | 07-Aug-2019 | Completed | Generating Revenue | |||
| 6. Grant | 05-Jul-2019 | $1.13K | $3.02M | Completed | Generating Revenue | |
| 5. Accelerator/Incubator | 01-Jan-2019 | $3.02M | Completed | Generating Revenue |
PD Neurotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Preferred D | ||||||||
| Preferred D | ||||||||
| Preferred C | ||||||||
| Preference | ||||||||
| Preference | 1,442 | $1.054475 | $1019.74 | $1019.74 | 1x | $1019.74 | 9.46% | |
| Ordinary | 1,646 | $1.054475 | $563.94 | $563.94 | 3x | $563.94 | 10.79% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
PD Neurotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PD Neurotechnology Patents
PD Neurotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4280947-A1 | Method for determination of sensor localization on the body of a user | Inactive | 14-Nov-2019 | ||
| US-20220280112-A1 | Method for determination of sensor localization on the body of a user | Inactive | 14-Nov-2019 | ||
| WO-2021094789-A1 | Method for determination of sensor localization on the body of a user | Inactive | 14-Nov-2019 | ||
| EP-3891756-A1 | Monitor system of multiple parkinson's disease symptoms and their intensity | Pending | 14-Dec-2018 | ||
| US-12465215-B2 | Monitor system of multiple parkinson's disease symptoms and their intensity | Active | 14-Dec-2018 | A61B5/0024 |
PD Neurotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PD Neurotechnology Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexander S. Onassis Public Benefit Foundation | Limited Partner | Minority | ||
| Crimson International Investment | Corporate Venture Capital | Minority | ||
| CIC Partners | PE/Buyout | Minority | ||
| Endeavor Greece | Accelerator/Incubator | |||
| Olympic Investments | Venture Capital | Minority |
PD Neurotechnology FAQs
-
When was PD Neurotechnology founded?
PD Neurotechnology was founded in 2015.
-
Where is PD Neurotechnology headquartered?
PD Neurotechnology is headquartered in London, United Kingdom.
-
What is the size of PD Neurotechnology?
PD Neurotechnology has 25 total employees.
-
What industry is PD Neurotechnology in?
PD Neurotechnology’s primary industry is Monitoring Equipment.
-
Is PD Neurotechnology a private or public company?
PD Neurotechnology is a Private company.
-
What is PD Neurotechnology’s current revenue?
The current revenue for PD Neurotechnology is .
-
How much funding has PD Neurotechnology raised over time?
PD Neurotechnology has raised $23.2M.
-
Who are PD Neurotechnology’s investors?
Alexander S. Onassis Public Benefit Foundation, Crimson International Investment, CIC Partners, Endeavor Greece, and Olympic Investments are 5 of 11 investors who have invested in PD Neurotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
